source
- Merck ends Phase 2 trial of Alzheimer’s drug MK-1167 from partner NeuphoriaMerck announced it has terminated a mid-stage Phase 2 study of an experimental Alzheimer’s therapy. The drug, called MK-1167, is an oral candidate that was being developed in collaboration with bi…
- WuXi AppTec seeks court order to remove itself from U.S. Pentagon's Chinese military-linked company listWuXi AppTec has filed a petition for a preliminary injunction to halt its inclusion on the Pentagon's list of firms with alleged ties to the Chinese military. The company says the designation is d…